VRC 309 (influenza DNA vaccine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VRC 309 (influenza DNA vaccine), covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years [Phase 1]